The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) was established in 1993. Inaugurated in Lisbon in 1995, it is one of the EU’s decentralised agencies. The EMCDDA exists to provide the EU and its Member States with a factual overview of European drug problems and a solid evidence base to support the drugs debate. Today it offers policymakers the data they need for drawing up informed drug laws and strategies. It also helps professionals and practitioners working in the field pinpoint best practice and new areas of research.
The EMCDDA was set up to provide 'factual, objective, reliable and comparable information concerning drugs, drug addiction and their consequences'
This two week in-person Summer School (26th of June to 7th of July 2023) prepares professionals and students to meet the complex policy challenges that face Europe and the World in the field of drugs.
Objective: to understand the short- and long-term responses of drug services to a major flux of displaced people and the related challenges.
Background: COVID-19 has raised attention in Europe, and globally, on the importance of monitoring preparedness towards potential emergencies.